SRF Q3 FY26 Earnings Conference Call Insight Note
SRF Ltd reported strong Q3 FY26 earnings, highlighting robust performance in its fluorochemicals segment despite challenges in specialty chemicals due to aggressive Chinese pricing pressure. While gross operating revenue rose by 6% to ₹3,713 crore, the specialty sector faced margin compression. The company continues to invest in expansion, particularly in pharmaceuticals, indicating a strategic shift to mitigate agrochemical volatility.
You must be logged in to post a comment.